Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AmerisourceBergen Corporation    ABC

AMERISOURCEBERGEN CORPORATION

(ABC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/15/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
106.8(c) 103.5(c) 103.79(c) 104.91(c) 107.76(c) Last
3 229 245 1 367 976 1 297 919 1 218 667 1 595 282 Volume
+1.10% -3.09% +0.28% +1.08% +2.72% Change
More quotes
Financials (USD)
Sales 2021 201 B - -
Net income 2021 1 583 M - -
Net cash position 2021 1 029 M - -
P/E ratio 2021 14,0x
Yield 2021 1,62%
Sales 2022 211 B - -
Net income 2022 1 693 M - -
Net cash position 2022 1 851 M - -
P/E ratio 2022 12,8x
Yield 2022 1,69%
Capitalization 22 058 M 22 058 M -
EV / Sales 2021 0,10x
EV / Sales 2022 0,10x
Nbr of Employees 21 500
Free-Float 51,1%
More Financials
Company
AmerisourceBergen Corporation specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services,... 
Read more
More about the company
Notations Surperformance© of AmerisourceBergen Corporation
Trading Rating : Investor Rating :
More Ratings
All news about AMERISOURCEBERGEN CORPORATION
01/21AMERISOURCEBERGEN : Argus Adjusts AmerisourceBergen's Price Target to $140 from ..
MT
01/14AMERISOURCEBERGEN : Keeps Quarterly Dividend Steady At $0.44 Per Share, Pay Date..
MT
01/14AMERISOURCEBERGEN : Announces Quarterly Dividend
BU
01/11AMERISOURCEBERGEN : UBS Adjusts Price Target on AmerisourceBergen to $121 From $..
MT
01/08AMERISOURCEBERGEN CORP : Entry into a Material Definitive Agreement, Regulation ..
AQ
01/07Walgreens maintains full-year profit growth forecast; shares rise
RE
01/07Walgreens Says Pandemic Hurting Visits to Pharmacies
DJ
01/07BED BATH & BEYOND, MICRON TECHNOLOGY : What to Watch When the Market Opens
DJ
01/07AMERISOURCEBERGEN : Walgreens tops fiscal 1Q forecasts as it fights pandemic hit
AQ
01/07WALGREENS BOOTS ALLIANCE : Tops Expectations in Fiscal First Quarter, Maintains ..
MT
01/07WALGREENS BOOTS ALLIANCE : Reports Stronger-Than-Expected 1Q Sales as Vaccine Di..
DJ
01/07Walgreens maintains full-year profit growth forecast; shares rise
RE
01/06WALGREENS BOOTS ALLIANCE : Accelerates Investment in VillageMD
DJ
01/06Health Care Up Amid Deal Activity -- Health Care Roundup
DJ
01/06Stocks End Mixed as Democrats Set to Take Control of Senate, Pro-Trump Rioter..
MT
More news
News in other languages on AMERISOURCEBERGEN CORPORATION
01/07PLANÈTE BOURSE : La revue de presse du jeudi 7 janvier 2021
01/06MÄRKTE USA/"Blaue Welle" trägt Dow erstmals über 31.000er Marke
01/06Amerisourcebergen débourse 6,5 milliards pour s'étendre en Europe
01/06MÄRKTE USA/Erwartung weiterer Stimuli sorgt für Rekordlaune
01/06MÄRKTE USA/Sieg der Demokraten drückt Technologiegiganten
More news
Analyst Recommendations on AMERISOURCEBERGEN CORPORATION
More recommendations
Stock Trading Strategies
AMERISOURCEBERGEN CORPORATION - 2020
The stock forcefully approaches new pivot levels
BUY
More Stock Trading Analysis
Analysis
Walgreens maintains full-year profit growth forecast; shares rise
Chart AMERISOURCEBERGEN CORPORATION
Duration : Period :
AmerisourceBergen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMERISOURCEBERGEN CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 121,35 $
Last Close Price 107,76 $
Spread / Highest target 39,2%
Spread / Average Target 12,6%
Spread / Lowest Target -3,49%
EPS Revisions
Managers and Directors
NameTitle
Steven H. Collis Chairman, President & Chief Executive Officer
James Francis Cleary Chief Financial Officer & Executive Vice President
Henry Wadsworth McGee Independent Director
Jane Ellen Henney Lead Independent Director
Michael J. Long Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
AMERISOURCEBERGEN CORPORATION7.31%22 058
ABBOTT LABORATORIES3.06%193 529
MEDTRONIC PLC-0.48%158 709
BECTON, DICKINSON AND COMPANY3.41%76 174
HOYA CORPORATION-4.52%48 389
ALIGN TECHNOLOGY, INC.-0.06%42 880
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ